NextFin

Trump-Xi November 2025 Agreement: Tariff Reductions, Export Control Easing, and Fentanyl Trade Commitments

NextFin news, On November 1, 2025, in the aftermath of a high-profile summit—referred to by President Trump as a "G2" meeting—between the United States President Donald Trump and Chinese President Xi Jinping in Busan, South Korea, both nations announced a consequential trade and security agreement. The deal centers around reductions in tariffs, adjustments in export controls, and new commitments related to fentanyl product tariffs and purchases.

Specifically, the agreement stipulates that the United States will halve tariffs on fentanyl-related products from 20% to 10%, while China commits to purchasing 12 million tonnes of American soybeans in 2025, with an annual minimum of 25 million tonnes projected over the next three years. Further, Beijing will suspend export controls on critical rare earth elements including gallium, germanium, and graphite—materials essential to advanced manufacturing and semiconductor industries. In tandem, the US will pause planned tariff hikes initially scheduled for November 2025.

Another notable provision allows Dutch chipmaker Nexperia BV’s Chinese facilities to resume exports, a move aimed at alleviating pressure on the global semiconductor supply chain. President Trump heralded the agreement as a landmark that could promote "everlasting peace and success" between the two largest economies. Nevertheless, experts emphasize the time-bound nature of these commitments, generally lasting one year, interpreting the accord as a temporary truce rather than a full resolution.

From a geopolitical lens, this agreement emerges amidst enduring geopolitical frictions and economic rivalry between the US and China. By easing tariffs and export controls, both nations aim to mitigate economic disruptions impacting key technological sectors and agricultural trade. The agreement’s agricultural component—China’s soybean purchases—is a direct response to US domestic stakeholders, especially farmers, who have been adversely affected by earlier rounds of trade disputes.

Economically, relaxing export controls on rare earth minerals is a critical development. China dominates global supply chains for these materials, indispensable for producing semiconductors, batteries, and other high-tech components. The inclusion of gallium and germanium suspension in export restrictions signals a moderation in Beijing’s strategic leverage tactics. Meanwhile, the resumption of exports by Nexperia’s Chinese operations should progressively stabilize semiconductor supplies, which have experienced volatility exacerbating global chip shortages, with implications for electronics, automotive, and defense sectors.

The fentanyl tariff reduction and cooperative stance reflect a recognition of the security dimensions interwoven with trade. The US has long targeted fentanyl precursors linked to opioid crises, and the easing might facilitate regulated trade while encouraging Chinese cooperation in curbing illicit fentanyl flows. However, halving tariffs rather than eliminating them outright suggests negotiation room and ongoing caution.

Data from previous years illustrate the trade war’s economic toll: US soybean exports to China plunged by more than 50% between 2018 and 2020 due to retaliatory tariffs, inflicting estimated losses of billions on US farmers. This renewed commitment to substantial purchases could potentially recapture some market share and boost rural economies. Nevertheless, uncertainties remain given the one-year horizon of the deal and the possibility of renewed tensions beyond that period.

Strategically, both powers seem to be balancing competitive rivalry with pragmatic coexistence. Trump's framing of the meeting as a "G2 summit" suggests a willingness to engage China as an equal counterpart in managing global economic order. Nonetheless, underlying contestations over technology dominance, human rights, and geopolitical influence are unresolved, limiting the depth of this truce.

Looking forward, this agreement may serve as a blueprint for incremental trade de-escalation but is unlikely to mark the end of US-China economic confrontations. Market participants and policymakers should watch closely for follow-through enforcement, especially on China's soybean purchases and export control suspensions. Further, the semiconductor industry will benefit if export normalizations continue but remains vulnerable to policy reversals given national security sensitivities.

In summary, the November 2025 Trump-Xi agreement represents a calibrated move to de-escalate specific tensions with measured commitments across tariffs, exports, and fentanyl trade controls. The limited duration and sector-specific nature indicate both parties are cautiously testing cooperation avenues without relinquishing strategic leverage in a still-contentious US-China relationship.

According to MercoPress, this accord not only eases immediate trade frictions but also underscores the complex interplay of economic interdependence and geopolitical rivalry shaping 21st-century global governance.

Explore more exclusive insights at nextfin.ai.

Open NextFin App